Vietnam Expands for 2025 with Addition of New Hall - The largest edition yet, nearly double the size of the 2023 edition. - ...

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with ... Gyre's financial information presented in ...

He added that the college’s in-demand programs, including nursing, computer science, and biotechnology, along with the ...

Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025 On track to initiate U.S. Phase 2 trial of F351 in MASH-associated liver fibrosis ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

This figure includes many college graduates, who typically have a broader area and more opportunities to canvas for their job ...

ZK International Group Co., Ltd. ("ZK International" or the "Company"), a leading engineering Company focused on high-performance steel products, is pleased to announce its preparation to accept ...

This is a registrational Phase 3, multi-center, randomized withdrawal ... titled "Non-GAAP Financial Measures" for more information. UCSD Neurological Institute (25K-75K, with ~10K new cases per year) ...

A team of scientists with the University of Tennessee, Knoxville, is participating as part of a larger team of industry and academic experts working to improve the lives ...

The investigators studied the membrane-targeting sequence (MTS) of bactofilin A (BacA) in Caulobacter crescentus to explore its role in membrane binding and polymerization. They used various ...